Wei Sun
15Patents
3h-index
30Co-inventors
56Inventor score
Filing activity: Apr 23, 2007 → Oct 18, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10099920B2 | Scalable nucleic acid-based nanofabrication | Performing Operations; Transporting | 11 | Active |
| US9062297B2 | Yersinia pestis vaccine | Emerging Cross-Sectional Technologies | 11 | Active |
| US9796748B2 | Spatial sequestration of dynamic nucleic acid circuits | Emerging Cross-Sectional Technologies | 3 | Active |
| US9598690B2 | Method for forming nanoparticles having predetermined shapes | Chemistry; Metallurgy | 2 | Active |
| US8124139B2 | Compound preparation for quickly reducing oxidative stress and preparation of the same | Human Necessities | 1 | Active |
| US9617392B2 | Compositions and methods for self-assembly of polymers with complementary macroscopic and microscopic scale units | Electricity | 1 | Active |
| US11073519B2 | Lateral flow testing | Physics | 0 | Active |
| US12214030B2 | Self-adjuvanting Yersinia outer membrane vesicle as a vaccine against plague, anthrax and pseudomonas infection | Human Necessities | 0 | Active |
| US10030241B2 | Methods and kits for capturing sperm nucleic acids | Chemistry; Metallurgy | 0 | Active |
| US11167019B2 | Self-adjuvanting yersinia outer membrane vesicle as a vaccine against plague, anthrax and pseudomonas infection | Human Necessities | 0 | Active |
| US11690919B2 | Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells | Human Necessities | 0 | Active |
| US11793840B2 | Nano-armored single cell product for treating Parkinson's disease through bacteria and a preparation method thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11826461B2 | Anti-hair loss and hair growth integrated core-shell microneedle patch | Performing Operations; Transporting | 0 | Active |
| US10280917B2 | Reciprocating low-speed heavy-load hydraulic pump with variable action area | Mechanical Engineering; Lighting; Heating | 0 | Active |
| US10226521B2 | Genetically modified Yersinia as vaccines against Yersinia species | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.